Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL213334 | 1.00 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL26109374 | 0.98 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11846081 | 0.98 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10654824 | 0.98 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL228041 | 0.98 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL10547596 | 0.98 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL4261280 | 0.95 | LMNA (0.52) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL1784806 | 0.93 | LMNA (0.55) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11761093 | 0.91 | LMNA (0.52) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL26106671 | 0.90 | LMNA (0.48) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113625471-B | Scleral lens | 上海艾康特医疗科技有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-113031306-B | Lens matching method of scleral contact lens | 上海艾康特医疗科技有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-113786862-B | Selective ketene hydrogenation catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113786862-A | Selective ketene hydrogenation catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-12-14 | — | — | CN | claimed |
| US-20210238214-A1 | GEMCITABINE AMPHIPHILE PRODRUGS | NanoMed Holdings Pty Ltd (AU) | 2021-08-05 | — | — | US | claimed |
| EP-3784681-A1 | GEMCITABINE AMPHIPHILE PRODRUGS | NanoMed Holdings Pty Ltd (AU) | 2021-03-03 | — | — | EP | claimed |
| EP-0816321-B1 | Process for producing 6-methyl-2-heptanone analogues, and process for producing phyton and isophytol | KURARAY CO (JP) | 2002-06-05 | — | — | EP | claimed |
| US-5955636-A | CROSS ALDOL CONDENSATION OF BRANCHED ALDEHYDE AND ACETONE; AQUEOUS ALKALI; HYDROGENATION CATALYST | KURARAY CO., LTD. (JP) | 1999-09-21 | — | — | US | claimed |
| EP-0816321-A1 | Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol | KURARAY CO., LTD. (JP) | 1998-01-07 | — | — | EP | claimed |
| US-12600805-B2 | Fluorine-containing alkyl ammonium borate compound and method for producing same | AGC Inc. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-12510770-B2 | Lenses and methods for affecting the progression of myopia | SHAMIR OPTICAL INDUSTRY LTD. (IL) | 2025-12-30 | — | — | US | disclosed |
| CN-114563880-B | Corneal contact lens and design method thereof | 上海艾康特医疗科技有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-114545659-B | Corneal contact lens and design method thereof | 上海艾康特医疗科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118614862-A | Virtual reality intelligent strabismus screening device with automatic covering function | 四川大学 | 2024-09-10 | — | — | CN | disclosed |
| EP-0816321-A1 | Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol | KURARAY CO., LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| US-5565489-A | MICROBIOCIDES, ANTITUMOR AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-10-15 | — | — | US | disclosed |
| EP-0670317-A1 | EPOXYCYCLOHEXENEDIONE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-09-06 | — | — | EP | disclosed |
| EP-0150952-B1 | PHOTOPOLYMERIZABLE COMPOSITION | KURARAY CO., LTD. (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-4668712-A | MONOMER, PHOTOINITIATOR, DENTAL FILLINGS | KURARAY CO., LTD. (JP) | 1987-05-26 | — | — | US | disclosed |
| EP-0150952-A2 | Photopolymerizable composition | KURARAY CO., LTD. (JP) | 1985-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238214-A1 | GEMCITABINE AMPHIPHILE PRODRUGS | GBA1, GMNN, TYMP | LMNA 2993/4885BLM 399/4885PTPN1 2884/4885 |
| US-12600805-B2 | Fluorine-containing alkyl ammonium borate compound and method for producing same | AFF1, AFF2, AFF4 | LMNA 1402/4885BLM 1311/4885PTPN1 3264/4885 |
| US-12510770-B2 | Lenses and methods for affecting the progression of myopia | STRA6, EYA3, RXFP3 | LMNA 179/4885BLM 2285/4885PTPN1 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.